Circulating tumor DNA fraction correlates with residual cancer burden postneoadjuvant chemotherapy in triple negative breast cancer patients

被引：0
|
作者：
Shan, Naing Lin
Gould, Billie
Blenman, Kim
Foldi, Julia
Du, Pan
Zhang, Frank
Walsh, Myles
Pusztai, Lajos
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-14-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-14-05
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer
    Pierga, J-Y.
    Riva, F.
    Houy, A.
    Saliou, A.
    Madic, J.
    Rampanou, A.
    Hego, C.
    Milder, M.
    Cottu, P.
    Sablin, M-P.
    Vincent-Salomon, A.
    Lantz, O.
    Stern, M-H.
    Proudhon, C.
    Bidard, F-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Dynamics of circulating tumor DNA during postoperative radiotherapy for triple-negative breast cancer in patients undergoing neoadjuvant chemotherapy and breast surgery
    Kim, H.
    Kim, Y. J.
    Park, D.
    Park, W. -Y.
    Choi, D. H.
    Park, W.
    Cho, W. K.
    BREAST, 2021, 56 : S48 - S48
  • [33] Circulating tumor DNA and burden of disease in breast cancer
    Hoffman, Abigail
    Aleshin, Alexey
    Banks, Kimberly
    Talasaz, AmirAli
    Eltoukhy, Helmy
    Telli, Melinda
    Wapnir, Irene
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 304 - 305
  • [34] Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors
    Nishimura, Tomomi
    Velaga, Ravi
    Masuda, Norikazu
    Kawaguchi, Kosuke
    Kawaguchi, Shuji
    Takada, Masahiro
    Maeshima, Yurina
    Tanaka, Sunao
    Kikawa, Yuichiro
    Kadoya, Takayuki
    Bando, Hiroko
    Nakamura, Rikiya
    Yamamoto, Yutaka
    Ueno, Takayuki
    Yasojima, Hiroyuki
    Ishiguro, Hiroshi
    Morita, Satoshi
    Ohno, Shinji
    Haga, Hironori
    Matsuda, Fumihiko
    Ogawa, Seishi
    Toi, Masakazu
    CANCER SCIENCE, 2024, 115 (12) : 3928 - 3942
  • [35] Importance of circulating tumor DNA analysis at diagnosis in early triple-negative breast cancer patients
    Park, Min-Seung
    Cho, Eun Hye
    Youn, Youngjin
    Do, In-Gu
    Woo, Hee-Yeon
    Park, Hyosoon
    Kim, Eun Young
    Kwon, Min-Jung
    BREAST CANCER, 2025, 32 (02) : 416 - 425
  • [36] Tumor mutation burden in triple negative breast cancer patients in Japan.
    Nagahashi, Masayuki
    Ling, Yiwei
    Hayashida, Tetsu
    Kitagawa, Yuko
    Futamura, Manabu
    Yoshida, Kazuhiro
    Kuwayama, Takashi
    Nakamura, Seigo
    Toshikawa, Chie
    Yamauchi, Hideko
    Yamauchi, Teruo
    Kaneko, Koji
    Kanbayashi, Chizuko
    Sato, Nobuaki
    Miyoshi, Yasuo
    Tsuchida, Junko
    Lyle, Stephen
    Takabe, Kazuaki
    Okuda, Shujiro
    Wakai, Toshifumi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients
    Agelaki, Sofia
    Dragolia, Melina
    Markonanolaki, Harris
    Alkahtani, Saad
    Stournaras, Christos
    Georgoulias, Vassilis
    Kallergi, Galatea
    ONCOTARGET, 2017, 8 (03) : 5309 - 5322
  • [38] Dynamic monitoring of circulating tumor DNA can predict chemotherapy response and prognosis in metastatic triple-negative breast cancer patients
    Li, Huihui
    Chi, Yajing
    Yin, Sha
    Yu, Bo
    Su, Mu
    Zhang, Baoxuan
    Qiang, Ling
    Ren, Guohua
    Song, Lihua
    Bu, Bing
    Fang, Shu
    Shang, Mao
    Tan, Qiaorui
    Man, Xiaochu
    CANCER RESEARCH, 2022, 82 (04)
  • [39] Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions
    Saliou, Adrien
    Bidard, Francois-Clement
    Lantz, Olivier
    Stern, Marc-Henri
    Vincent-Salomon, Anne
    Proudhon, Charlotte
    Pierga, Jean-Yves
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (01) : 39 - 50
  • [40] Circulating Tumor DNA Guides Prognosis in Metastatic Triple-Negative Breast Cancer
    Zivanovic Bujak, Andjelija
    Dawson, Sarah-Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 523 - 524
12345